P52564 (MP2K6_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 135.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Dual specificity mitogen-activated protein kinase kinase 6 Short name=MAP kinase kinase 6 Short name=MAPKK 6 EC=2.7.12.2 Alternative name(s): MAPK/ERK kinase 6 Short name=MEK 6 Stress-activated protein kinase kinase 3 Short name=SAPK kinase 3 Short name=SAPKK-3 Short name=SAPKK3 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 334 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. With MAP3K3/MKK3, catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in the MAP kinases p38 MAPK11, MAPK12, MAPK13 and MAPK14 and plays an important role in the regulation of cellular responses to cytokines and all kinds of stresses. Especially, MAP2K3/MKK3 and MAP2K6/MKK6 are both essential for the activation of MAPK11 and MAPK13 induced by environmental stress, whereas MAP2K6/MKK6 is the major MAPK11 activator in response to TNF. MAP2K6/MKK6 also phosphorylates and activates PAK6. The p38 MAP kinase signal transduction pathway leads to direct activation of transcription factors. Nuclear targets of p38 MAP kinase include the transcription factors ATF2 and ELK1. Within the p38 MAPK signal transduction pathway, MAP3K6/MKK6 mediates phosphorylation of STAT4 through MAPK14 activation, and is therefore required for STAT4 activation and STAT4-regulated gene expression in response to IL-12 stimulation. The pathway is also crucial for IL-6-induced SOCS3 expression and down-regulation of IL-6-mediated gene induction; and for IFNG-dependent gene transcription. Has a role in osteoclast differentiation through NF-kappa-B transactivation by TNFSF11, and in endochondral ossification and since SOX9 is another likely downstream target of the p38 MAPK pathway. MAP2K6/MKK6 mediates apoptotic cell death in thymocytes. Acts also as a regulator for melanocytes dendricity, through the modulation of Rho family GTPases. Ref.1 Ref.2 Ref.4 Ref.7 Ref.14 Ref.15 Ref.20 Ref.25 |
| Catalytic activity | ATP + a protein = ADP + a phosphoprotein. |
| Enzyme regulation | Activated by dual phosphorylation on Ser-207 and Thr-211 in response to a variety of cellular stresses, including UV radiation, osmotic shock, hypoxia, inflammatory cytokines, interferon gamma (IFNG), and less often by growth factors. MAP2K6/MKK6 is activated by the majority of M3Ks, such as MAP3K5/ASK1, MAP3K1/MEKK1, MAP3K2/MEKK2, MAP3K3/MEKK3, MAP3K4/MEKK4, MAP3K7/TAK1, MAP3K11/MLK3 and MAP3K17/TAOK2. Ref.2 Ref.4 Ref.24 |
| Subunit structure | Dimer. Interacts with Yersinia yopJ. Interacts (via its D domain) with its substrates MAPK11, MAPK12, MAPK13 and MAPK14 By similarity. Interacts (via its DVD domain) with MAP3Ks activators like MAP3K5/ASK1, MAP3K1/MEKK1, MAP3K2/MEKK2, MAP3K3/MEKK3, MAP3K4/MEKK4, MAP3K7/TAK1, MAP3K11/MLK3 and MAP3K17/TAOK2 By similarity. Interacts with DCTN1. Ref.11 Ref.19 Ref.28 |
| Subcellular location | Nucleus. Cytoplasm. Cytoplasm › cytoskeleton. Note: Binds to microtubules. Ref.8 |
| Tissue specificity | Isoform 2 is only expressed in skeletal muscle. Isoform 1 is expressed in skeletal muscle, heart, and in lesser extent in liver or pancreas. Ref.3 |
| Induction | Strongly activated by UV, anisomycin, and osmotic shock but not by phorbol esters, NGF or EGF. Ref.2 Ref.4 Ref.24 |
| Domain | The DVD domain (residues 311-334) contains a conserved docking site and is found in the mammalian MAP kinase kinases (MAP2Ks). The DVD sites bind to their specific upstream MAP kinase kinase kinases (MAP3Ks) and are essential for activation. Ref.21 The D domain (residues 4-19) contains a conserved docking site and is required for the binding to MAPK substrates By similarity. Ref.21 |
| Post-translational modification | Weakly autophosphorylated. Phosphorylated at Ser-207 and Thr-211 by the majority of M3Ks, such as MAP3K5/ASK1, MAP3K1/MEKK1, MAP3K2/MEKK2, MAP3K3/MEKK3, MAP3K4/MEKK4, MAP3K7/TAK1, MAP3K11/MLK3 and MAP3K17/TAOK2. Ref.4 Ref.9 Ref.10 Ref.11 Ref.12 Ref.16 Ref.17 Ref.18 Ref.22 Ref.24 Acetylation of Ser-207 and Thr-211 by Yersinia yopJ prevents phosphorylation and activation, thus blocking the MAPK signaling pathway. |
| Sequence similarities | Belongs to the protein kinase superfamily. STE Ser/Thr protein kinase family. MAP kinase kinase subfamily. Contains 1 protein kinase domain. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| LRRK2 | Q5S007 | 4 | EBI-448135,EBI-5323863 |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: P52564-1) Also known as: MKK6b; This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: P52564-2) Also known as: MKK6; The sequence of this isoform differs from the canonical sequence as follows: 1-56: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 334 | 334 | Dual specificity mitogen-activated protein kinase kinase 6 | PRO_0000086386 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 53 – 314 | 262 | Protein kinase | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Nucleotide binding | 59 – 67 | 9 | ATP By similarity | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Region | 4 – 19 | 16 | D domain By similarity | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Region | 311 – 334 | 24 | DVD domain | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Sites | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Active site | 179 | 1 | Proton acceptor By similarity | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Binding site | 82 | 1 | ATP By similarity | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Site | 14 – 15 | 2 | Cleavage; by anthrax lethal factor | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 207 | 1 | O-acetylserine; by Yersinia yopJ; alternate | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 207 | 1 | Phosphoserine; by MAP3K; alternate Ref.22 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 211 | 1 | O-acetylthreonine; by Yersinia yopJ; alternate | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 211 | 1 | Phosphothreonine; by MAP3K; alternate Ref.22 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 1 – 56 | 56 | Missing in isoform 2. | VSP_004882 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 207 | 1 | S → A: Inactivation. | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 207 | 1 | S → E: Constitutive activation according to PubMed:8622669, but not to PubMed:8621675. | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 211 | 1 | T → A: Inactivation. | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 211 | 1 | T → E: Constitutive activation according to PubMed:8622669, but not to PubMed:8621675. | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 125 | 1 | V → M in AAB03705. Ref.3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 125 | 1 | V → M in AAB03708. Ref.3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 50 – 52 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 53 – 61 | 9 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 63 – 72 | 10 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 73 – 76 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 77 – 84 | 8 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 90 – 104 | 15 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 110 – 112 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 115 – 120 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 122 – 130 | 9 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 133 – 135 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 136 – 145 | 10 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 152 – 172 | 21 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 182 – 184 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 185 – 187 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 193 – 195 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 201 – 203 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 207 – 212 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 222 – 225 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 236 – 252 | 17 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 263 – 272 | 10 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 280 – 282 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 285 – 294 | 10 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 299 – 301 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 305 – 308 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 312 – 319 | 8 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 324 – 332 | 9 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway." Raingeaud J., Whitmarsh A.J., Barrett T., Derijard B., Davis R.J. Mol. Cell. Biol. 16:1247-1255(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), MUTAGENESIS, FUNCTION. Tissue: Skeletal muscle. |
| [2] | "Cloning and characterization of MEK6, a novel member of the mitogen-activated protein kinase kinase cascade." Stein B., Brady H., Yang M.X., Young D.B., Barbosa M.S. J. Biol. Chem. 271:11427-11433(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, ENZYME REGULATION. Tissue: T-cell. |
| [3] | "Characterization of the structure and function of a novel MAP kinase kinase (MKK6)." Han J., Lee J.-D., Jiang Y., Li Z., Feng L., Ulevitch R.J. J. Biol. Chem. 271:2886-2891(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), TISSUE SPECIFICITY, MUTAGENESIS. Tissue: Placenta. |
| [4] | "A novel kinase cascade mediated by mitogen-activated protein kinase kinase 6 and MKK3." Moriguchi T., Kuroyanagi N., Yamaguchi K., Gotoh Y., Irie K., Kano T., Shirakabe K., Muro Y., Shibuya H., Matsumoto K., Nishida E., Hagiwara M. J. Biol. Chem. 271:13675-13679(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PHOSPHORYLATION, ENZYME REGULATION, FUNCTION. |
| [5] | "Purification and cDNA cloning of SAPKK3, the major activator of RK/p38 in stress- and cytokine-stimulated monocytes and epithelial cells." Cuenda A., Alonso G., Morrice N., Jones M., Meier R., Cohen P., Nebreda A.R. EMBO J. 15:4156-4164(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). |
| [6] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Urinary bladder. |
| [7] | "Activation of the novel stress-activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6); comparison of its substrate specificity with that of other SAP kinases." Goedert M., Cuenda A., Craxton M., Jakes R., Cohen P. EMBO J. 16:3563-3571(1997) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION IN ACTIVATION OF MAPK13. |
| [8] | "Nuclear export of the stress-activated protein kinase p38 mediated by its substrate MAPKAP kinase-2." Ben-Levy R., Hooper S., Wilson R., Paterson H.F., Marshall C.J. Curr. Biol. 8:1049-1057(1998) [PubMed] [Europe PMC] [Abstract] Cited for: SUBCELLULAR LOCATION. |
| [9] | "Human mitogen-activated protein kinase kinase kinase mediates the stress-induced activation of mitogen-activated protein kinase cascades." Chan-Hui P.Y., Weaver R. Biochem. J. 336:599-609(1998) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION BY MAP3K4. |
| [10] | "MEK kinase 3 directly activates MKK6 and MKK7, specific activators of the p38 and c-Jun NH2-terminal kinases." Deacon K., Blank J.L. J. Biol. Chem. 274:16604-16610(1999) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION BY MAP3K2/MEKK2 AND MAP3K3/MEK3. |
| [11] | "Isolation of the protein kinase TAO2 and identification of its mitogen-activated protein kinase/extracellular signal-regulated kinase kinase binding domain." Chen Z., Hutchison M., Cobb M.H. J. Biol. Chem. 274:28803-28807(1999) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH TAOK2, PHOSPHORYLATION BY TAOK2. |
| [12] | "The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway." Ninomiya-Tsuji J., Kishimoto K., Hiyama A., Inoue J., Cao Z., Matsumoto K. Nature 398:252-256(1999) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION BY MAP3K7/TAK1. |
| [13] | "Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor." Vitale G., Bernardi L., Napolitani G., Mock M., Montecucco C. Biochem. J. 352:739-745(2000) [PubMed] [Europe PMC] [Abstract] Cited for: CLEAVAGE BY ANTHRAX LETHAL FACTOR. |
| [14] | "Importance of the MKK6/p38 pathway for interleukin-12-induced STAT4 serine phosphorylation and transcriptional activity." Visconti R., Gadina M., Chiariello M., Chen E.H., Stancato L.F., Gutkind J.S., O'Shea J.J. Blood 96:1844-1852(2000) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [15] | "The MKK6/p38 mitogen-activated protein kinase pathway is capable of inducing SOCS3 gene expression and inhibits IL-6-induced transcription." Bode J.G., Ludwig S., Freitas C.A., Schaper F., Ruhl M., Melmed S., Heinrich P.C., Haussinger D. Biol. Chem. 382:1447-1453(2001) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [16] | "Negative feedback regulation of ASK1 by protein phosphatase 5 (PP5) in response to oxidative stress." Morita K., Saitoh M., Tobiume K., Matsuura H., Enomoto S., Nishitoh H., Ichijo H. EMBO J. 20:6028-6036(2001) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION BY MAP3K5/ASK1. |
| [17] | "Regulation of stress-responsive mitogen-activated protein (MAP) kinase pathways by TAO2." Chen Z., Cobb M.H. J. Biol. Chem. 276:16070-16075(2001) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION BY TAOK2. |
| [18] | "TAK1 is a ubiquitin-dependent kinase of MKK and IKK." Wang C., Deng L., Hong M., Akkaraju G.R., Inoue J., Chen Z.J. Nature 412:346-351(2001) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION BY MAP3K7/TAK1. |
| [19] | "p150(Glued), Dynein, and microtubules are specifically required for activation of MKK3/6 and p38 MAPKs." Cheung P.Y., Zhang Y., Long J., Lin S., Zhang M., Jiang Y., Wu Z. J. Biol. Chem. 279:45308-45311(2004) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH DCTN1, MICROTUBULE-BINDING. |
| [20] | "Activation of p21-activated kinase 6 by MAP kinase kinase 6 and p38 MAP kinase." Kaur R., Liu X., Gjoerup O., Zhang A., Yuan X., Balk S.P., Schneider M.C., Lu M.L. J. Biol. Chem. 280:3323-3330(2005) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION IN PHOSPHORYLATION OF PAK6. |
| [21] | "Conserved docking site is essential for activation of mammalian MAP kinase kinases by specific MAP kinase kinase kinases." Takekawa M., Tatebayashi K., Saito H. Mol. Cell 18:295-306(2005) [PubMed] [Europe PMC] [Abstract] Cited for: DOMAIN. |
| [22] | "Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation." Mukherjee S., Keitany G., Li Y., Wang Y., Ball H.L., Goldsmith E.J., Orth K. Science 312:1211-1214(2006) [PubMed] [Europe PMC] [Abstract] Cited for: ACETYLATION AT SER-207 AND THR-211, PHOSPHORYLATION AT SER-207 AND THR-211, INACTIVATION BY YERSINIA YOPJ, MASS SPECTROMETRY. |
| [23] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Cervix carcinoma. |
| [24] | "Mechanism of oxidative stress-induced ASK1-catalyzed MKK6 phosphorylation." Sturchler E., Feurstein D., McDonald P., Duckett D. Biochemistry 49:4094-4102(2010) [PubMed] [Europe PMC] [Abstract] Cited for: MASS SPECTROMETRY, PHOSPHORYLATION BY MAP3K5/ASK1, ENZYME REGULATION. |
| [25] | "MKK6 increases the melanocyte dendricity through the regulation of Rho family GTPases." Kim M.Y., Choi T.Y., Kim J.H., Lee J.H., Kim J.G., Sohn K.C., Yoon K.S., Kim C.D., Lee J.H., Yoon T.J. J. Dermatol. Sci. 60:114-119(2010) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [26] | "Signaling by dual specificity kinases." Dhanasekaran N., Premkumar Reddy E. Oncogene 17:1447-1455(1998) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW ON ENZYME REGULATION, REVIEW ON FUNCTION. |
| [27] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [28] | "The structure of the MAP2K MEK6 reveals an autoinhibitory dimer." Min X., Akella R., He H., Humphreys J.M., Tsutakawa S.E., Lee S.J., Tainer J.A., Cobb M.H., Goldsmith E.J. Structure 17:96-104(2009) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS) OF 45-332 OF MUTANT ASP-207 AND ASP-211, SUBUNIT. |
| [29] | "Crystal structure of human mitogen-activated protein kinase kinase 6 (mek6) activated mutant (s207d, t211d)." Structural genomics consortium (SGC) Submitted (JUL-2011) to the PDB data bank Cited for: X-RAY CRYSTALLOGRAPHY (2.26 ANGSTROMS) OF 47-334. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | U39657 mRNA. Translation: AAC50389.1. U39656 mRNA. Translation: AAC50388.1. U49732 mRNA. Translation: AAB05035.1. U39065 mRNA. Translation: AAB03705.1. U39064 mRNA. Translation: AAB03708.1. D87905 mRNA. Translation: BAA13496.1. X96757 mRNA. Translation: CAA65532.1. BC012009 mRNA. Translation: AAH12009.1. | ||||||||||||||||||||||||||||||
| IPI | IPI00003814. IPI00219569. | ||||||||||||||||||||||||||||||
| PIR | S71631. | ||||||||||||||||||||||||||||||
| RefSeq | NP_002749.2. NM_002758.3. | ||||||||||||||||||||||||||||||
| UniGene | Hs.463978. | ||||||||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||||||||
| ProteinModelPortal | P52564. | ||||||||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||||||||
| DIP | DIP-31346N. | ||||||||||||||||||||||||||||||
| IntAct | P52564. 7 interactions. | ||||||||||||||||||||||||||||||
| MINT | MINT-3019559. | ||||||||||||||||||||||||||||||
| STRING | 9606.ENSP00000351997. | ||||||||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||||||||
| PhosphoSite | P52564. | ||||||||||||||||||||||||||||||
Polymorphism databases | |||||||||||||||||||||||||||||||
| DMDM | 1709088. | ||||||||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||||||||
| PaxDb | P52564. | ||||||||||||||||||||||||||||||
| PRIDE | P52564. | ||||||||||||||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||||||||||||||
| DNASU | 5608. | ||||||||||||||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||||||||
| Ensembl | ENST00000589647; ENSP00000467213; ENSG00000108984. ENST00000590474; ENSP00000468348; ENSG00000108984. | ||||||||||||||||||||||||||||||
| GeneID | 5608. | ||||||||||||||||||||||||||||||
| KEGG | hsa:5608. | ||||||||||||||||||||||||||||||
| UCSC | uc002jii.3. human. | ||||||||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||||||||
| CTD | 5608. | ||||||||||||||||||||||||||||||
| GeneCards | GC17P067410. | ||||||||||||||||||||||||||||||
| HGNC | HGNC:6846. MAP2K6. | ||||||||||||||||||||||||||||||
| HPA | CAB007744. HPA031134. | ||||||||||||||||||||||||||||||
| MIM | 601254. gene. | ||||||||||||||||||||||||||||||
| neXtProt | NX_P52564. | ||||||||||||||||||||||||||||||
| PharmGKB | PA30591. | ||||||||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||||||||
| eggNOG | COG0515. | ||||||||||||||||||||||||||||||
| HOGENOM | HOG000234206. | ||||||||||||||||||||||||||||||
| HOVERGEN | HBG108518. | ||||||||||||||||||||||||||||||
| InParanoid | P52564. | ||||||||||||||||||||||||||||||
| KO | K04433. | ||||||||||||||||||||||||||||||
| OMA | ESAVAMV. | ||||||||||||||||||||||||||||||
| OrthoDB | EOG4P2Q2M. | ||||||||||||||||||||||||||||||
| PhylomeDB | P52564. | ||||||||||||||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||||||||||||||
| BRENDA | 2.7.12.2. 2681. | ||||||||||||||||||||||||||||||
| Pathway_Interaction_DB | anthraxpathway. Cellular roles of Anthrax toxin. il1pathway. IL1-mediated signaling events. il12_2pathway. IL12-mediated signaling events. il6_7pathway. IL6-mediated signaling events. p38_mkk3_6pathway. p38 MAPK signaling pathway. ar_tf_pathway. Regulation of Androgen receptor activity. p38alphabetapathway. Regulation of p38-alpha and p38-beta. p38gammadeltapathway. Signaling mediated by p38-gamma and p38-delta. mapktrkpathway. Trk receptor signaling mediated by the MAPK pathway. | ||||||||||||||||||||||||||||||
| Reactome | REACT_111045. Developmental Biology. REACT_6782. TRAF6 Mediated Induction of proinflammatory cytokines. REACT_6900. Immune System. | ||||||||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||||||||
| ArrayExpress | P52564. | ||||||||||||||||||||||||||||||
| Bgee | P52564. | ||||||||||||||||||||||||||||||
| CleanEx | HS_MAP2K6. | ||||||||||||||||||||||||||||||
| Genevestigator | P52564. | ||||||||||||||||||||||||||||||
| GermOnline | ENSG00000108984. Homo sapiens. | ||||||||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||||||||
| InterPro | IPR011009. Kinase-like_dom. IPR000719. Prot_kinase_cat_dom. IPR017441. Protein_kinase_ATP_BS. IPR002290. Ser/Thr_dual-sp_kinase_dom. IPR008271. Ser/Thr_kinase_AS. [Graphical view] | ||||||||||||||||||||||||||||||
| Pfam | PF00069. Pkinase. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||
| SMART | SM00220. S_TKc. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||
| SUPFAM | SSF56112. Kinase_like. 1 hit. | ||||||||||||||||||||||||||||||
| PROSITE | PS00107. PROTEIN_KINASE_ATP. 1 hit. PS50011. PROTEIN_KINASE_DOM. 1 hit. PS00108. PROTEIN_KINASE_ST. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||||||||
Other | |||||||||||||||||||||||||||||||
| BindingDB | P52564. | ||||||||||||||||||||||||||||||
| ChEMBL | CHEMBL2171. | ||||||||||||||||||||||||||||||
| EvolutionaryTrace | P52564. | ||||||||||||||||||||||||||||||
| GenomeRNAi | 5608. | ||||||||||||||||||||||||||||||
| NextBio | 21798. | ||||||||||||||||||||||||||||||
| PMAP-CutDB | P52564. | ||||||||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||||||||
Entry information
| Entry name | MP2K6_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P52564 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human and mouse protein kinases Human and mouse protein kinases: classification and index |
| Human chromosome 17 Human chromosome 17: entries, gene names and cross-references to MIM |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
